Chorioretinopathy Post COVID-19: A Systematic Review and Prevalence Assessment, Unveiling Insights into an Emerging Ocular Entity.
Mona Mahmoud ElsakkaMostafa Hossam El Din MoawadEman E LabeebMohamed ElnenyAbdelmonem SiddiqShereen GahlanIbraheem M AlkhawaldehHashem Abu SerhanPublished in: Seminars in ophthalmology (2024)
This systematic review states the prevalence and potential association between chorioretinopathy, and corticosteroid use in the context of COVID-19. This relation is still unclear because of the relief of symptoms in some cases after corticosteroid discontinuation, while two other cases were treated with corticosteroids and their symptoms improved.